Gibco EXPI293 Expression Media 6 x 1L, catalog # A1435102 and 2) EXPIFECTAMINE TRANSFXN KIT 10L 10L Kit Catalog# A14525

SEE BOM ATTACHED:

Document Type: Combined Synopsis/Solicitation

Solicitation Number: RFQ-NIAID-25-2244965

Posted Date: 10/21/2024

Response Date: 10/30/2023

Set Aside: none

NAICS Code: 325414

Classification Code: 6509

Contracting Office Address:

Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB,

Title: 1) EXPI293 Expression Medium 6 x 1L, catalog # A1435102

2) EXPIFECTAMINE TRANSFXN KIT 10L 10L Kit, Catalog #A14525

Primary Point of Contact:

Secondary Point of Contact

Calvin Robinson, calvin.robinson@nih.gov

Description:

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 Streamlined Procedures for Evaluation and solicitation for commercial Items, as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-25-2244965 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-03 February 23, 2024.

The North American Industry Classification System (NAICS) code for this procurement is 325414, Biological Product Manufacturing, with a size standard of 1250 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.

The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for the following Brand Name Supplies:

1. EXPI293 EXPRESSION MEDIUM 6 x 1L, cat #A1435102, QTY 36; to be delivered over six (6) scheduled deliveries shown below **EACH DELIVERY MUST SHIP PRODUCTS WITH THE FARTHEST EXTENDED EXPIRATION DATE

SHIPPING COSTS, if applicable

Delivery/scheduled shipping schedule:

Jan 29, 2025 QTY 6 EA

March 29, 2025 QTY 6 EA

May 29, 2025 QTY 6 EA

July 29, 2025 QTY 6 EA

Sept 29, 2025 QTY 6 EA

Nov 29, 2025 QTY 6 EA

1. EXPIFECTAMINE TRANSFXN KIT 10L 10L Kit Catalog# A14525 - ONE DELIVERY OF QTY 10 KITS, MUST SEND LOTS WITH FARTHEST EXTENDED EXPIRATION DATE

Place of Performance: NIH, 40 CONVENT DRIVE, BLDG 40 Vaccine Research Center, Bethesda, MD 20814, United States. FOB: Destination

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following: technical capability to meet the requirements and price.

The following FAR provisions apply to this acquisition:

FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (FEB 2024)

FAR 52.204-7 System for Award Management (OCT 2018)

(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements Representation (JAN 2017)

52.204 26 Covered Telecommunications Equipment or Services-Representation

(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26

The following FAR contract clauses apply to this acquisition:

FAR 52-212-4 Contract Terms and Conditions Commercial Items (NOV 2022)

FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (FEB 2024)

*The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting.

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)

FAR 52.204-13 System for Award Management Maintenance (OCT 2018)

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)

HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015)

FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: http://farsite.hill.af.mil/vffara.htm

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.

Submission shall be received not later than October 30, 2024 @ 2:00 EST

All quotations and required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov. All vendors must register in the eSASS system to submit a quotation. Instructions on how to register / submit quotes are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.